These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38637504)

  • 1. Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.
    Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
    Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
    Pu L; Su L; Kang X
    Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
    Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
    Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
    Deng G; Wang F; Song Y
    Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
    Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
    Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy related 4B, upregulated by HIF-1α, attenuates the sensitivity to cisplatin in nasopharyngeal carcinoma cells.
    Huang J; Li HB; Yu S; Yuan F; Lou ZP
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4793-4802. PubMed ID: 32432742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
    Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
    Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
    Fernández-Nogueira P; Mancino M; Fuster G; López-Plana A; Jauregui P; Almendro V; Enreig E; Menéndez S; Rojo F; Noguera-Castells A; Bill A; Gaither LA; Serrano L; Recalde-Percaz L; Moragas N; Alonso R; Ametller E; Rovira A; Lluch A; Albanell J; Gascon P; Bragado P
    Clin Cancer Res; 2020 Mar; 26(6):1432-1448. PubMed ID: 31699826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
    Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
    Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
    Lou JS; Zhao LP; Huang ZH; Chen XY; Xu JT; Tai WC; Tsim KWK; Chen YT; Xie T
    Phytomedicine; 2021 Jan; 80():153370. PubMed ID: 33113504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 14. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
    Liu Q; Wang K
    Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis.
    Yuan F; Lou Z; Zhou Z; Yan X
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
    Han L; Li L; Wu G
    Mol Cell Probes; 2022 Aug; 64():101821. PubMed ID: 35490795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
    Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
    Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.